Regional hyperthermia (RHT) combined with gemcitabine (G) plus cisplatin (P) in patients (pts) with advanced pancreatic adenocarcinoma (APC)

被引：0
|
作者：
Tschoep, K. E. [1 ]
Milani, V. [1 ]
Lindner, L. H. [1 ]
Boeck, S. [1 ]
Berger, F. [2 ]
Dieterle, N. [1 ]
Abdel-Rahman, S. [1 ]
Salat, C. [3 ]
Issels, R. D. [1 ]
机构：
[1] Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Klin Nukl Med, D-8000 Munich, Germany
[3] Hamatoonkol Schwerpunktpraxis & Tagesklin, Munich, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [1] Regional hyperthermia (RHT) as an innovative treatment component: RHT combined with gemcitabine (G) and cisplatin (CIS) in G-pretreated advanced pancreatic cancer (APC)
    Tschoep-Lechner, K.
    Dieterle, N.
    Abdel-Rahman, S.
    Lindner, L.
    Salat, C.
    Ehrke, S.
    Weber, B.
    Bruns, C. J.
    Heinemann, V.
    Mansmann, U.
    Issels, R. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Regional hyperthermia (RHT) combined with gemcitabine (GEM) plus cisplatin (CIS) in patients with GEM-refractory advanced pancreatic cancer: Results of the ESHO phase II trial
    Tschoep, K. E.
    Boeck, S.
    Berger, F.
    Maier, V.
    Abdel-Rahman, S.
    Kuhlencordt, M.
    Salat, C.
    Schmidt, M.
    Heinemann, V.
    Issels, R. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] GEMCITABINE AND CISPLATIN COMBINED WITH REGIONAL HYPERTHERMIA AS SECOND-LINE TREATMENT IN PATIENTS WITH GEMCITABINE-REFRACTORY ADVANCED PANCREATIC CANCER
    Lechner, Katharina
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf
    ANNALS OF ONCOLOGY, 2012, 23 : 62 - 62
  • [4] Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Tschoep-Lechner, Katharina Elisabeth
    Milani, Valeria
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf-Dieter
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2013, 29 (01) : 8 - 16
  • [5] Combination chemotherapy with gemcitabine and cisplatin in patients (pts) with advanced pancreatic cancer
    Agbarya, Abed
    Ben-Shachar, Menachem
    Nasrallah, Suheil
    Faraggi, David
    Vered, Shiraz
    Epelbaum, Ron
    ANNALS OF ONCOLOGY, 2006, 17 : 321 - 321
  • [6] Gemcitabine and cisplatin combined with regional hyperthermia as salvage therapy for patients with recurrent pancreatic cancer after adjuvant gemcitabine chemotherapy
    Tschoep-Lechner, K.
    Salat, C.
    Weber, B.
    Dieterle, N.
    Abdel-Rahman, S.
    Berger, F.
    Lindner, L.
    Boeck, S.
    Issels, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (05) : 478 - 478
  • [7] Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomized clinical trial
    Issels, Rolf D.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial
    Issels, Rolf D.
    Boeck, Stefan
    Pelzer, Uwe
    Mansmann, Ulrich
    Ghadjar, Pirus
    Lindner, Lars H.
    Albertsmeier, Markus
    Angele, Martin K.
    Schmidt, Michael
    Xu, Yujun
    Bahra, Marcus
    Pratschke, Johann
    Schoenberg, Michael
    Thasler, Wolfgang E.
    Salat, Christoph
    Stoetzer, Oliver J.
    Knoefel, Wolfram T.
    Graf, Dirk
    Wessalowski, Rudiger
    Keitel-Anselmino, Verena
    Koenigsrainer, Alfred
    Bitzer, Michael
    Zips, Daniel
    Bamberg, Michael
    Fietkau, Rainer
    Ott, Oliver
    Kawecki, Maciej
    Wyrwicz, Lucian
    Rutkowski, Piotr
    Rentsch, Markus
    Ababei, Juliana
    Reichardt, Peter
    Rigamonti, Marco
    Weber, Bernhard
    Abdel-Rahman, Sultan
    Tschoep-Lechner, Katharina
    Jauch, Karl-Walter
    Bruns, Christiane J.
    Oettle, Helmut
    von Bergwelt-Baildon, Michael
    Heinemann, Volker
    Werner, Jens
    EUROPEAN JOURNAL OF CANCER, 2023, 181 : 155 - 165
  • [9] A phase II study of erlotinib in patients (pts) with advanced pancreatic cancer (APC) who are refractory to gemcitabine (G)
    Iyer, R.
    Khushalani, N.
    Tan, W.
    Litwin, A.
    LeVea, C.
    Hutson, A.
    Tucker, C.
    Ma, W.
    Fakih, M.
    Adjei, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 391 - 391
  • [10] A randomised phase II study of cetuximab plus gemcitabine/cisplatin combination in advanced pancreatic cancer (APC)
    Cascinu, S.
    Berardi, R.
    Labianca, R.
    Siena, S.
    Falcone, A.
    Aitini, E.
    Barni, S.
    Di Costanzo, F.
    Frontini, L.
    Tonini, G.
    Rota, S.
    Floriani, I.
    Zaniboni, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 18 - 18
12345